ARTICLE | Company News
Chugai, Galderma deal
August 1, 2016 7:00 AM UTC
Chugai granted Galderma exclusive, worldwide rights to develop and commercialize nemolizumab outside of Japan and Taiwan. Chugai will receive an undisclosed upfront cash payment and is eligible for mi...